INO
Inovio Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.43
+5.15%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-1542.6%
Return on equity
-136.5%
Return on assets
-640.6%
Return on invested capital
0.00x
Asset turnover
-$80.6M
Cash from operations
$0.35
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026